Compare BIO & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | CHE |
|---|---|---|
| Founded | 1952 | 1970 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.8B |
| IPO Year | N/A | 1994 |
| Metric | BIO | CHE |
|---|---|---|
| Price | $285.94 | $419.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $339.75 | ★ $501.50 |
| AVG Volume (30 Days) | ★ 431.5K | 187.2K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.84 |
| Revenue | N/A | ★ $2,529,978,000.00 |
| Revenue This Year | $2.74 | $6.56 |
| Revenue Next Year | $3.20 | $6.23 |
| P/E Ratio | ★ $9.72 | $86.96 |
| Revenue Growth | N/A | ★ 4.06 |
| 52 Week Low | $222.80 | $365.21 |
| 52 Week High | $343.12 | $562.77 |
| Indicator | BIO | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 44.86 |
| Support Level | $256.85 | $419.30 |
| Resistance Level | $288.48 | $453.11 |
| Average True Range (ATR) | 9.54 | 12.65 |
| MACD | -2.00 | -2.34 |
| Stochastic Oscillator | 1.12 | 14.36 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.